<style face="normal" font="default" size="100%">Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">High-Throughput Sequencing of microRNAs in Glucocorticoid Sensitive Paediatric Inflammatory Bowel Disease Patients.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Pharmacogenetics of treatments for inflammatory bowel disease.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Theophylline as a precision therapy in a young girl with PIK3R1 immunodeficiency.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Carbamazepine-induced thrombocytopenic purpura in a child: Insights from a genomic analysis.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Differential expression of GAS5 in rapamycin-induced reversion of glucocorticoid resistance.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome.</style>